BioLine CEO Holds Shares Amid Market Volatility, Signals Long‑Term Confidence
BioLine RX CEO keeps steady 5.1m shares, shows confidence amid market drop & GLIX1 trial, hinting long‑term growth & potential upside for shareholders.
3 minutes to read
BioLine RX Ltd